Human parechoviruses: Biology, epidemiology and clinical significance

被引:158
作者
Harvala, H. [1 ]
Simmonds, R. [2 ]
机构
[1] Royal Infirm Edinburgh NHS Trust, Specialist Virol Ctr, Edinburgh EH16 4SA, Midlothian, Scotland
[2] Univ Edinburgh, Ctr Infect Dis, Edinburgh EH9 1QH, Midlothian, Scotland
关键词
Parechovirus; Picornavirus; Clinical presentation; Diagnosis; Epidemiology; Genetic variability; REAL-TIME PCR; ACCELERATING FACTOR CD55; VIRUS TYPE 22; YOUNG-CHILDREN; MOLECULAR EPIDEMIOLOGY; PICORNAVIRUS GROUP; COXSACKIEVIRUS A9; CELLULAR RECEPTOR; CAPSID PROTEIN; STOOL SAMPLES;
D O I
10.1016/j.jcv.2009.03.009
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Human parechoviruses (HPeVs) are members of the large and growing family of Picornaviridae. Although originally described as echovirus 22 and 23 within human enteroviruses because of their clinical and morphological properties, they have since been shown to be distinct from this and other picornavirus groups in several features of their genome organisation, structure and replication. Human parechoviruses show genetic and antigenic heterogeneity and a number of distinct HPeV types are known to circulate widely in human populations throughout the World. Although the Majority of HPeV infections occur early in life without specific symptoms, disease manifestations associated with many of the Currently described types have been described, ranging from gastroenteritis and respiratory infections to neurological disease, particularly in neonates. Although HPeV diagnosis has historically been made by virus isolation, a new generation of sensitive and specific molecular tests for HPeV RNA promises to greatly improve the effectiveness of HPeV detection and type identification, as well as providing a greater understanding its molecular epidemiology. By this means, we will learn much more about the clinical relevance of HPeVs and the association of different HPeV types with specific disease presentations. (C) 2009 Elsevier B.V. All rights reserved.
引用
收藏
页码:1 / 9
页数:9
相关论文
共 86 条
[61]  
RODRIGUEZ PL, 1993, J BIOL CHEM, V268, P8105
[62]   ENTRY OF COXSACKIEVIRUS A9 INTO HOST-CELLS - SPECIFIC INTERACTIONS WITH ALPHA(V)BETA(3) INTEGRIN, THE VITRONECTIN RECEPTOR [J].
ROIVAINEN, M ;
PIIRAINEN, L ;
HOVI, T ;
VIRTANEN, I ;
RIIKONEN, T ;
HEINO, J ;
HYYPIA, T .
VIROLOGY, 1994, 203 (02) :357-365
[63]  
RUSSELL SJM, 1970, LANCET, V1, P784
[64]   ATP hydrolysis and AMP kinase activities of nonstructural protein 2C of human parechovirus 1 [J].
Samuilova, O ;
Krogerus, C ;
Fabrichniy, I ;
Hyypiä, T .
JOURNAL OF VIROLOGY, 2006, 80 (02) :1053-1058
[65]   Specific interaction between human parechovirus nonstructural 2A protein and viral RNA [J].
Samuilova, O ;
Krogerus, C ;
Pöyry, T ;
Hyypiä, T .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2004, 279 (36) :37822-37831
[66]   Evidence of recombination among enteroviruses [J].
Santti, J ;
Hyypiä, T ;
Kinnunen, L ;
Salminen, M .
JOURNAL OF VIROLOGY, 1999, 73 (10) :8741-8749
[67]   Characterization of echovirus 22 variants [J].
Schnurr, D ;
Dondero, M ;
Holland, D ;
Connor, J .
ARCHIVES OF VIROLOGY, 1996, 141 (09) :1749-1758
[68]   Polyprotein processing in echovirus 22: A first assessment [J].
Schultheiss, T ;
Emerson, SU ;
Purcell, RH ;
GaussMuller, V .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1995, 217 (03) :1120-1127
[69]   Circulation of type 1 vaccine-derived poliovirus in the Philippines in 2001 [J].
Shimizu, H ;
Thorley, B ;
Paladin, FJ ;
Brussen, KA ;
Stambos, V ;
Yuen, L ;
Utama, A ;
Tano, Y ;
Arita, M ;
Yoshida, H ;
Yoneyama, T ;
Benegas, A ;
Roesel, S ;
Pallansch, M ;
Kew, O ;
Miyamura, T .
JOURNAL OF VIROLOGY, 2004, 78 (24) :13512-13521